Cooper Companies (COO) surged 12.94% in pre-market trading following a robust fiscal Q4 earnings report and the announcement of a strategic review aimed at enhancing shareholder value. The medical device maker reported non-GAAP earnings of $1.15 per share, beating analyst estimates of $1.11, while revenue rose to $1.07 billion, surpassing expectations of $1.06 billion.
The company also initiated a formal strategic review to explore opportunities such as partnerships, divestitures, and mergers, which has garnered positive investor sentiment. Additionally, Cooper appointed Colleen Jay as its new Board Chair, effective January 2026, further boosting confidence in the company's leadership and future direction.
Comments